EMERGENT BIOSOLUTIONS INC. Other Long-term Debt, Current
EMERGENT BIOSOLUTIONS INC. (EBS) had Other Long-term Debt, Current of $3.28 million as of 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLongTermDebtCurrent · last filed 2012-05-04
- 2012-03-31: Other Long-term Debt, Current $3.28M.
- 2011-12-31: Other Long-term Debt, Current $5.36M.
- 2010-12-31: Other Long-term Debt, Current $17.19M.
| Period end | Other Long-term Debt, Current |
|---|---|
| 2012-03-31 | $3.28M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $5.36M 10-Q · filed 2012-05-04 |
| 2010-12-31 | $17.19M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |